Objective To evaluate the impact of anti-Tumour Necrosis Factor-α (anti-TNF) treatment on
the occurrence of vasculitic ischaemic events in patients with deficiency of adenosine …

Abstract Purpose of Review We aim to describe the pathophysiology, clinical findings,
diagnosis, and treatment of deficiency of adenosine deaminase 2 (DADA2). Recent Findings …

Objective Deficiency of adenosine deaminase 2 (DADA2) is a potentially fatal monogenic
syndrome characterized by variable manifestations of systemic vasculitis, bone marrow …

Objectives To analyse the prevalence of CECR1 mutations in patients diagnosed with early
onset livedo reticularis and/or haemorrhagic/ischaemic strokes in the context of inflammation …

Objective. Deficiency of adenosine deaminase 2 (DADA2) is an autosomal recessive
autoinflammatory disorder associated with ADA2 mutations. We aimed to investigate the …

Background Deficiency of adenosine deaminase 2 (DADA2) is a rare autoinflammatory
disease usually presenting before the age of 10 years. Non-specific clinical features or late …

Objective Individuals with deficiency of adenosine deaminase 2 (DADA 2), a recently
recognized autosomal recessive disease, present with various systemic vascular and …

Objective We aimed to test the relevance of deficiency of adenosine deaminase 2 (DADA2)
in patients with antibody deficiency and describe the clinical picture of the disease in …

Deficiency of adenosine deaminase type 2 (DADA2) is a rare form of autoinflammatory
disorder with limited reported cases. In this paper, we have presented the clinico …

There are a number of original features in this series. To our knowledge, this is the first
report of DADA2 patients developing progressive and debilitating renal findings (FSGS …